sk&f-38393 has been researched along with cabergoline in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fujinami, A; Kuno, S; Matsui, H; Mizuta, I; Ohta, K; Ohta, M | 1 |
Cai, L; Guo, YH; Le, WD; Leng, ZG; Lin, SJ; Lou, MQ; Shang, HB; Tang, H; Wu, ZB; Wu, ZR; Xue, YJ; Zhang, X; Zhao, W; Zhao, WG | 1 |
2 other study(ies) available for sk&f-38393 and cabergoline
Article | Year |
---|---|
Effects of dopamine agonists bromocriptine, pergolide, cabergoline, and SKF-38393 on GDNF, NGF, and BDNF synthesis in cultured mouse astrocytes.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Astrocytes; Blotting, Northern; Brain-Derived Neurotrophic Factor; Bromocriptine; Cabergoline; Dopamine Agonists; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Ergolines; Glial Cell Line-Derived Neurotrophic Factor; Mice; Mice, Inbred ICR; Nerve Growth Factor; Nerve Growth Factors; Pergolide; Receptors, Dopamine D1; Receptors, Dopamine D2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors | 2003 |
Activation of DRD5 (dopamine receptor D5) inhibits tumor growth by autophagic cell death.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Autophagosomes; Autophagy; Cabergoline; Cell Line, Tumor; Cell Proliferation; Ergolines; Humans; Mice, Nude; Pituitary Neoplasms; Rats; Reactive Oxygen Species; Receptors, Dopamine D5; Superoxide Dismutase; TOR Serine-Threonine Kinases | 2017 |